Re: A structured debate: Immediate versus deferred androgen suppression in prostate cancer-evidence for deferred treatment

被引：0
|
作者：
Schellhammer, PF [1 ]
机构：
[1] Eastern Virginia Med Sch, Virginia Prostate Ctr, Dept Urol, Norfolk, VA 23501 USA
[2] Sentara Canc Inst, Norfolk, VA USA
来源：
JOURNAL OF UROLOGY | 2002年 / 168卷 / 05期
关键词：
D O I：
10.1016/S0022-5347(05)64325-X
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2130 / 2131
页数：2
相关论文
共 50 条
  • [31] Treatment strategies after a single seizure - Rationale for immediate versus deferred treatment
    Miller, Laura C.
    Drislane, Frank W.
    CNS DRUGS, 2007, 21 (02) : 89 - 99
  • [32] Early androgen suppression may reduce disease progression and improve long term survival compared with deferred androgen suppression in locally advanced prostate cancer
    Akaza, H
    CANCER TREATMENT REVIEWS, 2003, 29 (03) : 224 - 225
  • [33] Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure
    Leone, Maurizio A.
    Giussani, Giorgia
    Nevitt, Sarah J.
    Marson, Anthony G.
    Beghi, Ettore
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (05):
  • [34] Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure
    Leone, Maurizio A.
    Giussani, Giorgia
    Nolan, Sarah J.
    Marson, Anthony G.
    Beghi, Ettore
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (05):
  • [35] Localised prostate cancer: radical prostatectomy or deferred treatment strategy
    Borkowetz, Angelika
    UROLOGE, 2021, 60 (04): : 504 - 508
  • [36] IMMEDIATE, COMPARED TO DEFERRED, COMBINED ANDROGEN BLOCKADE PROLONGS TIME TO CASTRATE-RESISTANT LNCAP PROSTATE CANCER PROGRESSION IN VIVO
    Kuruma, Hidetoshi
    Gust, Kilian
    Matsumoto, Hiroaki
    Zoubeidi, Amina
    Thomas, Chirstian
    Lamoureux, Francois
    Gleave, Martin
    JOURNAL OF UROLOGY, 2011, 185 (04): : E247 - E247
  • [37] Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council trial
    Adib, RS
    Anderson, JB
    Ashken, MH
    Baumber, CD
    Bevis, CRA
    Beynon, LL
    Blaxland, JW
    Boag, V
    Bolger, JJ
    Boreham, J
    Bramble, FJ
    Breakey, J
    Bullock, KN
    Burrett, J
    Carswell, GF
    Charlton, CAC
    Chilton, CP
    Chisholm, GD
    Clack, R
    Claridge, M
    Clark, PB
    Coulton, ER
    Cox, SR
    Cresswell, SM
    Crowther, J
    Davies, M
    DeSousa, BA
    Deane, RF
    Devereux, MH
    Doyle, PT
    English, P
    Evans, CM
    Fellows, GJ
    Fernie, CGM
    Fordham, M
    French, ME
    Gaches, CGC
    Gallegos, CRR
    Gilliland, EL
    Glaholm, J
    Glashan, RW
    Grant, JBP
    Grayson, CEA
    Green, NA
    Griffin, S
    Hall, RR
    Hafner, B
    Hargreave, TB
    Harrison, GSM
    Heal, MR
    BRITISH JOURNAL OF UROLOGY, 1997, 79 (02): : 235 - 246
  • [38] Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study
    Garcia-Albeniz, X.
    Chan, J. M.
    Paciorek, A.
    Logan, R. W.
    Kenfield, S. A.
    Cooperberg, M. R.
    Carroll, P. R.
    Hernan, M. A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (07) : 817 - 824
  • [39] Immediate versus deferred hormonal treatment for patients with prostate cancer who are not suitable for curative local treatment: Results of the randomized trial SAKK 08/88
    Studer, UE
    Hauri, D
    Hanselmann, S
    Chollet, D
    Leisinger, HJ
    Gasser, T
    Senn, E
    Trinkler, FB
    Tscholl, RM
    Thalmann, GN
    Dietrich, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (20) : 4109 - 4118
  • [40] Re: Surveillance and Deferred Treatment for Localized Prostate Cancer. Population Based Study in the National Prostate Cancer Register of Sweden
    Gasser, Thomas
    EUROPEAN UROLOGY, 2009, 56 (01) : 219 - 219
12345